Variant report
Variant | rs3088301 |
---|---|
Chromosome Location | chr2:113372330-113372331 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113346800-113374600 | Weak transcription | Ovary | ovary |
2 | chr2:113348600-113383600 | Weak transcription | Brain Cingulate Gyrus | brain |
3 | chr2:113349000-113384000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
4 | chr2:113357800-113375200 | Weak transcription | Stomach Smooth Muscle | stomach |
5 | chr2:113357800-113384200 | Weak transcription | Pancreas | Pancrea |
6 | chr2:113358000-113384000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr2:113364600-113372800 | Weak transcription | Fetal Stomach | stomach |
8 | chr2:113370400-113383800 | Weak transcription | Fetal Muscle Leg | muscle |
9 | chr2:113370600-113377800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr2:113371600-113372800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:113371600-113372800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr2:113371600-113372800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr2:113371600-113374000 | Enhancers | HepG2 | liver |
14 | chr2:113371600-113382000 | Weak transcription | Spleen | Spleen |
15 | chr2:113371800-113372400 | Genic enhancers | Gastric | stomach |
16 | chr2:113371800-113372600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr2:113371800-113372600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr2:113371800-113373000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr2:113371800-113373200 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr2:113371800-113373200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr2:113371800-113373200 | Strong transcription | Brain Germinal Matrix | brain |
22 | chr2:113372000-113372400 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
23 | chr2:113372000-113372400 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
24 | chr2:113372000-113372400 | Flanking Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
25 | chr2:113372000-113372400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
26 | chr2:113372000-113372400 | Strong transcription | Brain Anterior Caudate | brain |
27 | chr2:113372000-113372600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
28 | chr2:113372000-113372600 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
29 | chr2:113372000-113372600 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
30 | chr2:113372000-113372600 | Enhancers | Fetal Thymus | thymus |
31 | chr2:113372000-113372600 | Enhancers | K562 | blood |
32 | chr2:113372000-113372800 | ZNF genes & repeats | H9 Derived Neuron Cultured Cells | ES cell derived |
33 | chr2:113372000-113373000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
34 | chr2:113372000-113373000 | Strong transcription | Fetal Brain Female | brain |
35 | chr2:113372200-113372400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
36 | chr2:113372200-113372800 | Enhancers | H9 Cell Line | embryonic stem cell |
37 | chr2:113372200-113372800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
38 | chr2:113372200-113373000 | Strong transcription | Skeletal Muscle Male | skeletal muscle |
39 | chr2:113372200-113379800 | Weak transcription | Fetal Muscle Trunk | muscle |
40 | chr2:113372200-113384200 | Weak transcription | Fetal Intestine Small | intestine |